HPLC Method Development for the Separation and Quantitative Determination of Rg1 and Re Ginsenosides from Tissue Culture
Main Article Content
Abstract
Ginsenosides are triterpenoid saponins found in Panax ginseng. They are well known for their health benefits, including antioxidant, anticancer, and antidiabetic effects, along with their support for cardiovascular and neurological function. Our previous study showed that cultivating Panax ginseng in tissue culture successfully led to its rapid growth. Several active compounds, including Rg1 and Re ginsenosides, were identified in the powdered extract of cultivated Panax ginseng. As part of a continuous study, an analytical method was developed to ensure the consistency of yield composition with the required quality standards. The analytical method optimization involved selecting the mobile phase composition and adjusting the flow rate in both isocratic and gradient systems to achieve optimal separation. The gradient elution system, with a constant flow rate of 1.0 mL/min, was more effective than the isocratic system for separating ginsenosides. The optimized method was then validated, showing acceptable validation parameters. The validated method was applied to the ginsenosides assay in the powdered extract of the Panax ginseng sample. Eight out of fourteen ginsenosides were identified, including Rg1 and Re, which were quantified at 0.16% and 0.45%, respectively. A baseline resolution of about 5.16 between Rg1 and Re ginsenosides was achieved. The analytical method developed using HPLC in this study effectively separated ginsenoside compounds simultaneously. These findings proposed an analytical method to evaluate the quality standards of ginsenosides in Panax ginseng.
Downloads
Article Details

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
1. Chung IM, Lim JJ, Ahn MS, Jeong HN, An TJ, Kim SH. Comparative phenolic compound profiles and antioxidative activity of the fruit, leaves, and roots of Korean ginseng (Panax ginseng Meyer) according to cultivation years. J Ginseng Res. 2016; 40(1): 68-75.
2. Ratan ZA, Haidere MF, Hong YH, Park SH, Lee JO, Lee J, Cho JY. Pharmacological potential of ginseng and its major component ginsenosides. J Ginseng Res. 2021; 45(2): 199-210.
3. Amelia R, Pahlevi MFP, Ash-Shiddiq Ikhsan AA, Andini N, Nadyah S. Herbal Medicine as an Alternative Management for Prediabetes: A Review. Trop J Nat Prod Res. 2024; 8(12): 9701-9707.
4. Yun YB, Kwon HY, Um Y. Changes in growth characteristics and ginsenoside contents of wild-simulated ginseng with different harvest times in South Korea. Appl Biol Chem. 2024; 67(1): 66.
5. Sukweenadhi J, Chandra SP, Putra LS, Vianney YM, Liliani T, Wongso M, Widjaja M, Pramadiyanti S, Christanti P, Hak KJ, Yang DC. The Effect of Elisitor on Growth and Ginsenoside Level in Hairy Root Culture of Panax ginseng Cultivated in Shake Flasks. E3S Web of Con 374. 2023; 00019: 1-5.
6. Yang Y, Ren C, Zhang Y, Wu X. Ginseng: an nonnegligible natural remedy for healthy aging. Aging Dis. 2017; 8(6): 708-720.
7. Xu F, Valappil AK, Mathiyalagan R, Tran TNA, Ramadhania ZM, Awais M, Yang DC. In vitro cultivation and ginsenosides accumulation in Panax ginseng: a review. Plants. 2023; 12(17): 3165.
8. Kusuma DY, Kristanti AN, Wibowo AT, Tan BC, Manuhara YSW. Optimization of Biomass and Secondary Metabolite Production in Gynura procumbens (Lour.) Merr. Adventitious Roots Culture by Using the Method of Subculture and Fed-batch Cultivation in a Bioreactor. J Biosci. 2023; 30(5): 797-807.
9. Setiabudi J, Bintang KMOS, Gani SS, Christanti P, Putri EN, Kang SC, Sukweenadhi J. Effect of fluidised bed drying on ginsenoside content in hairy root cultures of Panax ginseng CA Meyer. J Biotech. 2023; 28(3):137-142.
10. Kang OJ, Kim JS. Comparison of ginsenoside contents in different parts of Korean ginseng (Panax ginseng CA Meyer). Prev Nutr Food Sci. 2016; 21(4): 389-392.
11. Choi GS, Shin JS, Kim W, Baik MY. Increases in Ginsenoside Rg3, Compound K, and Antioxidant Activity of Cultivated Wild Panax Ginseng (CWPG) by Puffing. Foods. 2022; 11(19): 2936.
12. Kim JH, Yi YS, Kim MY, Cho JY. Role of ginsenosides, the main active components of Panax ginseng, in inflammatory responses and diseases. J Ginseng Res. 2017; 41(4): 435-443.
13. Makky EA. Korean Red Ginseng: Benefits Versus Precautions. ITPS. 2018; 1(1): 10-13.
14. Murugesan M, Mathiyalagan R, Boopathi V, Kong BM, Choi SK, Lee CS, Yang DC, Kang SC. Production of minor ginsenoside CK from major ginsenosides by biotransformation and its advances in targeted delivery to tumor tissues using nanoformulations. Nanomaterials. 2022; 12(19): 3427.
15. Zhang H, Abid S, Ahn JC, Mathiyalagan R, Kim YJ, Yang DC, Wang Y. Characteristics of Panax ginseng cultivars in Korea and China. Molecules. 2020; 25(11): 2635.
16. Chu LL, Huy NQ, Tung NH. Microorganisms for ginsenosides biosynthesis: recent progress, challenges, and perspectives. Molecules. 2023; 28(3): 1437.
17. Zhao J, Shi Z, Liu S, Li J, Huang W. Ginsenosides Rg1 from Panax ginseng: a potential therapy for acute liver failure patients?. Evid Based Comp Alternat Med. 2014; 2014(1): 538059.
18. Gao Y, Chu S, Zhang Z, Chen N. Hepataprotective effects of ginsenoside Rg1–A review. J Ethnopharmacol. 2017; 206:178-183.
19. Yang SJ, Wang JJ, Cheng P, Chen LX, Hu JM, Zhu GQ. Ginsenoside Rg1 in neurological diseases: From bench to bedside. Acta Pharmacol Sin. 2023; 44(5): 913-930.
20. Mohanan P, Subramaniyam S, Mathiyalagan R, Yang DC. Molecular signaling of ginsenosides Rb1, Rg1, and Rg3 and their mode of actions. J Ginseng Res. 2018; 42(2): 123-132.
21. Gao XY, Liu GC, Zhang JX, Wang LH, Xu C, Yan ZA, Wang A, Su YF, Lee JJ, Piao GC, Yuan HD. Pharmacological properties of ginsenoside Re. Pharmacology. 2022; 13: 754191.
22. PubChem Ginsenoside Rg1. [online]. [cited 2025 Feb 10]. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/441923.
23. PubChem Ginsenoside Re. [online]. [cited 2025 Feb 10]. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/441921.
24. Xiu Y, Li X, Sun X, Xiao D, Miao R, Zhao H, Liu S. Simultaneous determination and difference evaluation of 14 ginsenosides in Panax ginseng roots cultivated in different areas and ages by high-performance liquid chromatography coupled with triple quadrupole mass spectrometer in the multiple reaction–monitoring mode combined with multivariate statistical analysis. J Ginseng Res. 2019; 43(4): 508-516.
25. Qi LW, Wang CZ, Yuan CS. Isolation and analysis of ginseng: advances and challenges. Nat Prod Rep. 2011; 28(3): 467-495.
26. Yang Y, Ju Z, Yang Y, Zhang Y, Yang L, Wang Z. Phytochemical analysis of Panax species: a review. J Ginseng Res. 2021; 45(1): 1-21.
27. Hu Y, Li Y, Shen Y, Zhang B, Liu J, Cao Y, Zhao J. Targeted preparation of six rare ginsenosides using two β-glucosidases from Bifidobacterium adolescentis. Food Bios. 2024; 59: 104192.
28. Renchinkhand G, Magsar U, Bae HC, Choi SH, Nam MS. Identification of β-glucosidase activity of Lentilactobacillus buchneri URN103L and its potential to convert ginsenoside Rb1 from Panax ginseng. Foods. 2022; 11(4): 529.
29. Abid S, Kaliraj L, Rahimi S, Kim YJ, Yang DC, Kang SC, Balusamy SR. Synthesis and characterization of glycol chitosan coated selenium nanoparticles acts synergistically to alleviate oxidative stress and increase ginsenoside content in Panax ginseng. Carbohydr Polym. 2021; 267: 118195.
30. Zhang N, Yang Y, Li C, Zhang K, Xiaochen GAO, Shen J, Wang Y, Cheng D, Lv J, Sun J. Based on 1H NMR and LC-MS metabolomics reveals biomarkers with neuroprotective effects in multi-parts ginseng powder. Arab. J. Chem. 2023; 16: 104840.
31. Xue P, Yang X, Zhao L, Hou Z, Zhang R, Zhang F, Ren G. Relationship between antimicrobial activity and amphipathic structure of ginsenosides. Indus Crops Prod 143. 2020; 111929: 1-11.
32. Fastre RJV, Faes ML, Vanhaelen MH. High-performance thin-layer chromatographic determination of six major ginsenosides in Panax ginseng. Chromatography. 2000; 868(2): 269-276.
33. Wang H, Teng Y, Li S, Li Y, Li H, Jiao L, Wu W. UHPLC-MS-Based serum and urine metabolomics reveals the anti-diabetic mechanism of ginsenoside Re in type 2 diabetic rats. Molecules. 2021; 26(21): 6657.
34. Sun Y, Fu X, Qu Y, Chen L, Liu, X, He Z, Xu J, Yang J, Ma W, Li J, Guo Q, Zhang Y. Characterization of Ginsenosides from the Root of Panax ginseng by Integrating Untargeted Metabolites Using UPLC-Triple TOF-MS. Molecules. 2023; 28(5): 2068.
35. Wang Y, Choi HK, Brinckmann JA, Jiang X, Huang L. Chemical analysis of Panax quinquefolius (North American ginseng): A review. J Chromatography. 2015; 1426: 1-15.
36. Baek SH, Bae ON, Park JH. Recent methodology in ginseng analysis. J Ginseng Res. 2012; 36(2): 119.
37. Xu L, Xu, J, Shi G, Xiao S, Dai R, Wu S, Sun B, Zhang X, Zhao Y. Optimization of flash extraction, separation of ginsenosides, identification by HPLC-FT-ICR-MS and determination of rare ginsenosides in mountain cultivated ginseng. RSC Adv. 2020; 10(72): 44050-44057.
38. Thu DT. Simultaneous determination of Notoginsenoside R1 and ginsenosides Rg1, Re, Rb1 in dietary supplements by HPLC-DAD. 2021; 4(2): 160-170.
39. Chen F, Luo J, Kong L. Fast isolation of ginsenosides Re and Rg1 from the roots of Panax ginseng by HSCCC-ELSD combined with MCI gel CC guided by HPLC-MS. J Liq Chrom & Rel Tech. 2012; 35(7): 912-923.
40. Snyder LR., Kirkland JJ., Dolan JW. Introduction To Modern Liquid Chromatography. (3rd ed.). Canada: John Wiley & Sons, Inc; 2010. 54 p.
41. Hsu BY, Jen CT, Inbaraj BS, Chen BH. A comparative study on analysis of ginsenosides in American ginseng root residue by HPLC-DAD-ESI-MS and UPLC-HRMS-MS/MS. Mol-ecules. 2022; 27(10): 3071.
42. Schellinger AP, Carr PW. Isocratic and gradient elution chromatography: a comparison in terms of speed, retention reproducibility and quantitation. J Chrom. 2006; 1109(2): 253-266.
43. Wang HP, Zhang YB, Yang XW, Zhao DQ, Wang YP. Rapid characterization of ginsenosides in the roots and rhizomes of Panax ginseng by UPLC-DAD-QTOF-MS/MS and simultaneous determination of 19 ginsenosides by HPLC-ESI-MS. J Ginseng Res. 2016; 40(4): 382-394.
44. Hsu BY, Chen CH, Lu TJ, Hwang LS. Bioconversion of Ginsenosides in the American Ginseng (Xī Yáng Shēn) Extraction Residue by Fermentation with Lingzhi (Líng Zhī, Ganoderma Lucidum). J Tradit Comp Med. 2013; 3(2): 95-101.
45. Sarker SD, Nahar L. Applications of high-performance liquid chromatography in the analysis of herbal products. Amsterdam: Elsevier Inc; 2015: 405-425 p.
46. Yao F, Li X, Sun J, Cao X, Liu M, Li Y, Liu Y. Thermal transformation of polar into less-polar ginsenosides through demalonylation and deglycosylation in extracts from ginseng pulp. Scien Rep. 2021; 11(1): 1513.
47. Schellinger AP, Stoll DR, Carr PW. High-speed gradient elution reversed-phase liquid chromatography of bases in buffered eluents: Part II. Full equilibrium. Chromatography. 2008; 1192(1): 54-61.
48. Lu JM, Yao Q, Chen C. Ginseng compounds: an update on their molecular mechanisms and medical applications. Curr Vasc Pharmacol. 2009; 7(3): 293-302.
49. Germán Acacio JM, Meza-Sánchez DE, Morales-Morales D. Therapeutically relevant natural products as AMPK activators in the treatment of diabetes. S Nat Prod Chem. 2020; 66: 57-90.
50. Zhang L, Wang S, Qu B, Chi H, Quan Y, Wu X. Efficient separation determination of protopanaxatriol ginsenosides Rg1, Re, Rf, Rh1, Rg2 by HPLC. J Pharm Biomed. 2019; 170: 48-53.